drugset / Trial / NCT06087731
Efficacy and Safety of Tocilizumab for TAO
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate the efficacy and safety of tocilizumab treating Thyroid Associated Ophthalmopathy.
Timeline
- Start
- 2023-09-23
- Primary completion
- 2023-09-23
- Completion
- 2023-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | 8 mg/kg | — |